Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.

doi:10.1016/s1701-2163(16)32349-0

Article

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC - 1 Jan 2007

Horsman Doug, Wilson Brenda J, Avard Denise, Meschino Wendy S, Kim Sing Charmaine, Plante Marie, Eisen Andrea, Howley Heather E, Simard Jacques

Abstract excerpt

BACKGROUND: In Canada, there are wide variations in services for patients at risk for hereditary breast and ovarian cancer (HBOC), and clinical interventions and recommendations differ between regions and/or provinces. National strategies for the clinical management of HBOC exist in the United Kingdom, France, and Australia, and clinical programs in Canada would benefit from similar national recommendations and a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.

Abstract excerpt

Topics

Related research